期刊文献+

晚期糖化终末产物在去卵巢大鼠骨质疏松发病中的作用及氨基胍防治效果 被引量:1

The role of AGEs in the pathogenesis of ovariectomy-induced osteoporosis and prevention and treatment with aminoguanidine
暂未订购
导出
摘要 目的 探讨晚期糖化终末产物 (AGEs)在去卵巢大鼠骨质疏松发病中的作用及氨基胍防治效果。方法 选用 1 0月龄大鼠通过卵巢切除诱导骨质疏松并用氨基胍防治其骨量丢失 ,测定其骨密度及骨胶原中 AGEs的含量及血、尿生化指标。结果 卵巢切除大鼠骨密度 (0 .2 0 7g/cm2 ± 0 .0 1 6 g/cm2 )明显低于假手术大鼠 (0 .2 36 g/cm2 ± 0 .0 1 0 g/cm2 ) (P<0 .0 1 ) ,而骨胶原 AGEs含量 (59.86 RU/mg胶原± 3.1 3 RU/mg胶原 )明显高于假手术组大鼠 (53.83RU/mg胶原± 5.46RU/mg胶原 ) (P<0 .0 1 )。卵巢切除大鼠血清雌激素 (4.50 pg/ml± 1 .73pg/ml)与假手术组(8.45 pg/ml± 2 .90 pg/ml)比较明显降低 (P<0 .0 2 ) ,2 4 h尿钙、尿钙与肌酐比值、尿磷、尿磷与肌酐比值均有升高趋势。卵巢切除大鼠给予氨基胍后骨密度 (0 .2 2 1 g/cm2± 0 .0 1 7g/cm2 )明显升高 (P<0 .0 5) ,骨胶原中 AGEs含量 (51 .2 3RU/mg胶原± 7.46RU/mg胶原 )明显降低 (P<0 .0 1 ) ,血清雌激素 (8.59pg/ml± 3.0 1 pg/ml)明显升高 (P<0 .0 1 ) ,2 4 h尿钙、尿钙与肌酐比值降低 ,2 4 h尿羟脯氨酸升高 ,与手术组比较有显著差异 (P<0 .0 5)。结论 卵巢切除后 ,雌激素的降低和 AGEs的增加是导致骨质疏松的主要原因。而氨基胍通过降低体内 Objective Exploring the role of advanced glycosylation end products in the pathogenesis of ovariectomy-induced osteoporosis and prevention and treatment for ovariectomy-induced osteoporosis with aminoguanidine. Methods 10 months rats were ovariectomized to induce osteoporosis in this study.Determining bone mineral density, contents of AGEs from bone collagen,biochemical indexes in serum and urine which related to bone metabolism.Results Contents of AGE from ovariectomized rats' bone collagen (59.86RU/mg collagen±3.13 RU/mg collagen) were higher than that from sham group(53.83 RU/mg collagen ±5.46 RU/mg collagen) (P<0.01).Bone mineral density(0.207g/crn2±0. 010 g/crn2) were significantly reduced in the ovariectomized rats compared with that in sham group (0.236 g/ crn2±0.017 g/ crn2) (P<0.01).Levels of Serum estrogen (4.50pg/ml±1.73pg/ml) in ovariectomized rats had a decrease compared with that in sham group (8.45pg/ml±2.90pg/ml ) (P<0.02). Levels of Ca/Cr, contents of Ca, Levels of P/Cr, contents of P in ovariectomized rats' urine have an increased tendency. Tibia bone mineral density (0.221 g/ crn2±0.017 g/ crn2) from the ovariectomized rats given with aminoguanidine was higher compared with that in ovariectomized rats (P<0.05). Contents of AGEs(51.23 RU/mg collagen±7.46 RU/mg collagen) from bone collagen in ovariectomized rats given with aminoguanidine were lower than that from ovariectomized rats (P<0.01). Levels of Serum estrogen (8.59pg/ml±3.01pg/ml ) in ovariectomized rats given with aminoguanidine had an increase compared with that in ovariectomized rats (P<0.01). Levels of Ca/Cr, contents of Ca, contents of HOP from urine in ovariectomized rats given with aminoguanidine remarkably decreased compared with that in ovariectomized rats.Conclusions Increased AGEs contents from bone collagen in ovariectomized rats and decreased serum estrogen levels resulted in the reduced bone formation absolutely and the increased bone resorption relatively by multiplex ways. Which was responsible for the pathogenesis of postmenopausal osteoporosis and Aminoguanidine can prevent ovariectomized rat from bone loss by repressing the AGE production.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2003年第1期40-42,共3页 Chinese Journal of Gerontology
关键词 晚期糖化终末产物 去卵巢大鼠 骨质疏松 绝经 氨基胍 Advanced glycosylation end products Ovariectomy Osteoporosis Bone mineral density Estrogen
  • 相关文献

参考文献3

二级参考文献2

共引文献81

同被引文献10

  • 1曾名勇,崔海英,李八方.海洋生物活性肽及其生物活性研究进展[J].中国海洋药物,2005,24(1):46-51. 被引量:27
  • 2蒲首丞,王金水.生物活性肽的制备与应用[J].粮食加工,2005,30(5):49-51. 被引量:26
  • 3陈照坤.围绝经期妇女肥胖与2型糖尿病发生的关系[J].护理研究(上旬版),2005,19(9):1733-1734. 被引量:4
  • 4李仪奎.中药药理实验方法[M].上海:科学技术出版社,1991.175--176,203--204.
  • 5Diamond MP,Grainger D,Diamond MC,et al.Effects of methyltestosterone on insulin secretion and sensitivity in women[J].J Clin Endocrinol Metab,1998;83:4420.
  • 6Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the women's health initiative randomized controlled trial[J].JAMA,2002;288(3):321-33.
  • 7Li RJ,Qiu SD,Chen HX,et al.The immunotherapeutic effects of astragalus polysacchari-de in type 1 diabetic mice[J].Biol Pharm Bull,2007;30(3):470-6.
  • 8Iwamoto T,Watanabe S,Nishimura M.Inhibition of low-density lipoprotein oxidation by fish protein (mackeral peptide)[C].11th International Symposium on Atherosclerosis,Paris,1997:223.
  • 9Jeon YJ,Byun HG,Kim SK.Improvement of functional properties of cod frame protein hydrolysates using ult rafilt ration membranes[J].Proc Biochem,1999;35(5):471.
  • 10程爱娟,王佩显.雌激素及其受体对心血管系统保护作用实验研究进展[J].中国心血管杂志,2003,8(5):377-379. 被引量:11

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部